A placebo-controlled double blind trial of hydroxychloroquine in mild-to-moderate COVID-19
bioRxiv (2020) - Comments
doi: 10.1101/2020.10.19.20214940 

Vincent Dubee, Pierre-Marie Roy, Bruno Vielle, Elsa Parot-Schinkel, Odile Blanchet, Astrid Darsonval, Caroline Lefeuvre, Chadi Abbara, Sophie Boucher, Edouard Devaud, Olivier Robineau, Patrick Rispal, Thomas Guimard, Emma D'Anglejan, Sylvain Diamantis, Marc-Antoine Custaud, Isabelle Pellier, Alain Mercat